Skip to main content
. 2022 Aug 11;13:927179. doi: 10.3389/fphar.2022.927179

FIGURE 4.

FIGURE 4

Effectiveness of biological disease-modifying anti-rheumatic drugs compared to Janus kinase inhibitors. bDMARD: biological disease-modifying anti-rheumatic drug; JAKi: Janus kinase inhibitors.